Effects of Intranasal Oxytocin in the Treatment of Benzodiazepine Withdrawal: A Pilot RCT

NCT06757517 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Benzodiazepine Dependence

Interventions

DRUG: Oxytocin nasal spray
DRUG: Saline (NaCl 0,9 %) (placebo)

Sponsor

St. Olavs Hospital

Collaborators

[object Object]
[object Object]